Inventor profile of:

Jung-Ae Kim

City:

Daegu

Country:

South Korea

Published Applications:

10

Last publication date:

2021-02-18

Top Assignees for applications by Jung-Ae Kim

The entities that hold a legal rights for patent applications filed by inventor Kim Jung-Ae:

Recent patent applications by Kim Jung-Ae

Jung-Ae Kim from Daegu, KR has applied for patents for these inventions. The list has both pending applications and granted patents:

#1 | 2021-02-18
US20210047301A1
Chemistry; metallurgy

2-cyanopyrimidin-4-yl carbamate or urea derivative or salt thereof, and pharmaceutical composition including same

#2 | 2019-01-10
US20190010125A1
Chemistry; metallurgy

Pyridinol derivative or pharmaceutically acceptable salt thereof, and pharmaceutical composition containing same as active ingredient

#3 | 2018-12-27
US20180370964A1
Chemistry; metallurgy

Pharmaceutical composition containing, as active ingredient, 7-azaindolin-2-one derivative or pharmaceutically acceptable salt thereof

#4 | 2016-12-08
US20160354352A1
Human necessities

Method of treating inflammatory bowel disease comprising administering a pharmaceutical composition comprising a 6-aminopyridin-3-ol compound or a pharmaceutically acceptable salt thereof as an active ingredient to a subject

#5 | 2016-03-10
US20160068489A1
Chemistry; metallurgy

Amidopyridinol derivative or pharmaceutically acceptable salt thereof and pharmaceutical composition comprising same as active component

#6 | 2015-11-12
US20150320729A1
Human necessities

Pharmaceutical composition comprising bicyclic pyridinol derivatives for preventing or treating diseases caused by angiogenesis

#7 | 2015-08-27
US20150238471A1
Human necessities

6-aminopyridine-3-ol derivatives or pharmaceutically acceptable salts thereof, and pharmaceutical composition containing same as active ingredients for preventing or treating diseases caused by angiogenesis

#8 | 2015-01-29
US20150031890A1
Chemistry; metallurgy

PHARMACEUTICAL COMPOSITION COMPRISING BICYCLIC PYRIDINOL DERIVATIVES FOR PREVENTING OR TREATING DISEASES CAUSED BY ANGIOGENESIS

#9 | 2013-11-14
US20130303600A1
Human necessities

Anti-angiogenic composition containing macrolactin A and a derivative thereof as active ingredients

#10 | 2013-05-02
US20130109745A1
Human necessities

ANTI-ANGIOGENIC COMPOSITION CONTAINING MACROLACTIN A AND A DERIVATIVE THEREOF AS ACTIVE INGREDIENTS

InventorID:

224418 ⎘